To hear about similar clinical trials, please enter your email below
Trial Title:
The Effect of Natural Molecules on HPV Infection
NCT ID:
NCT06661083
Condition:
HPV (Human Papillomavirus)-Associated
Conditions: Official terms:
Papillomavirus Infections
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Dietary Supplement
Intervention name:
EGCG, FA, HA, B12
Description:
EGCG + FA + HA + B12 (1 cps /die)
Arm group label:
Patients with HPV infection
Summary:
The purpose of the study is to the effect of the administration of natural molecules in
the treatment of infections with HPV.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- HPV DNA test positivity
Exclusion Criteria:
- pregnancy
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Agunco
Address:
City:
Rome
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Vittorio Unfer, MD
Phone:
+390640500651
Email:
vunfer@gmail.com
Start date:
August 1, 2024
Completion date:
February 2025
Lead sponsor:
Agency:
AGUNCO Obstetrics and Gynecology Centre
Agency class:
Other
Source:
AGUNCO Obstetrics and Gynecology Centre
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06661083
